We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$15.1M
Cap. Flow
-$22.7M
Cap. Flow %
-13.45%
Top 10 Hldgs %
33.65%
Holding
197
New
30
Increased
43
Reduced
28
Closed
35

Top Buys

Rank Stock Value
1
ASPN icon
Aspen Aerogels
ASPN
+$3.04M
2
VCNX
Vaccinex, Inc. Common Stock
VCNX
+$2.57M
3
ALIM
Alimera Sciences
ALIM
+$1.96M
4
OUST icon
Ouster
OUST
+$1.74M
5
SILC icon
Silicom
SILC
+$1.63M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$5.37M
2
ANIP icon
ANI Pharmaceuticals
ANIP
+$4.71M
3
AVNW icon
Aviat Networks
AVNW
+$1.76M
4
ANVS icon
Annovis Bio
ANVS
+$1.14M
5
CMBM
Cambium Networks
CMBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 15.95%
2 Technology 14.24%
3 Financials 7.09%
4 Industrials 3.96%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECPG icon
126
PUT
Encore Capital Group
ECPG
$2.06B
$4.84K ﹤0.01%
+11,000
New +$540K
W icon
127
PUT
Wayfair
W
$11.8B
$4.28K ﹤0.01%
37,600
+2,600
+7% +$181K
RCUS icon
128
PUT
Arcus Biosciences
RCUS
$3.47B
$3.81K ﹤0.01%
10,900
– –
HASI icon
129
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.93B
$2.78K ﹤0.01%
+10,100
New +$243K
CCL icon
130
PUT
Carnival Corporation Ltd
CCL
$39.4B
$2.39K ﹤0.01%
119,400
-56,000
-32% -$928K
X
131
PUT
DELISTED
US Steel
X
$1.11K ﹤0.01%
13,900
+2,100
+18% +$58.9K
AMH icon
132
American Homes 4 Rent
AMH
$12.4B
– –
-6,598
Closed -$234K
ANIP icon
133
ANI Pharmaceuticals
ANIP
$1.82B
– –
-87,472
Closed -$4.71M
APLS
134
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-21,800
Closed -$13.9K
APPS icon
135
Digital Turbine
APPS
$1.09B
– –
-43,053
Closed -$400K
ARLO icon
136
Arlo Technologies
ARLO
$1.63B
– –
-10,668
Closed -$116K
AZN icon
137
CALL
AstraZeneca
AZN
$245B
– –
-23,600
Closed -$68.4K
BCLI
138
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-11,704
Closed -$362K
CMBM
139
DELISTED
Cambium Networks
CMBM
– –
-73,841
Closed -$1.12M
VISN
140
Vistance Networks Inc
VISN
$2.72B
– –
-16,450
Closed -$92.6K
CTLP
141
DELISTED
Cantaloupe
CTLP
– –
-15,978
Closed -$127K
DEA
142
Easterly Government Properties
DEA
$1.17B
– –
-5,720
Closed -$207K
ELS icon
143
Equity Lifestyle Properties
ELS
$12.7B
– –
-4,430
Closed -$296K
EVLV icon
144
Evolv Technologies
EVLV
$1.02B
– –
-24,588
Closed -$148K
GILD icon
145
CALL
Gilead Sciences
GILD
$163B
– –
-23,400
Closed -$33K
GSK icon
146
PUT
GSK
GSK
$103B
– –
-33,200
Closed -$1.66K
ITOS
147
DELISTED
iTeos Therapeutics
ITOS
– –
-10,900
Closed -$144K
KRG icon
148
Kite Realty
KRG
$5.69B
– –
-15,200
Closed -$340K
MTN icon
149
Vail Resorts
MTN
$5.32B
– –
-943
Closed -$237K
MTLS
150
Materialise
MTLS
$377M
– –
-31,190
Closed -$269K
3 4 5
6
7

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Worth Venture Partners held 197 positions worth $169M, down 8.2% from $184M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Worth Venture Partners withdrew a net $22.7M in Q3 2023, closing 35 positions and reducing 28 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Worth Venture Partners opened a new position in Aspen Aerogels worth $3.68M.

  • Worth Venture Partners's largest Q3 2023 buy was Aspen Aerogels: 428,367 shares worth $3.68M.
  • Worth Venture Partners added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $2.57M increase.
  • Worth Venture Partners's biggest Q3 2023 reduction was Microchip Technology, cutting an estimated $5.37M.
  • Worth Venture Partners fully exited ANI Pharmaceuticals in Q3 2023, selling an estimated $4.71M.
  • Worth Venture Partners's ten largest holdings make up 34% of its $169M portfolio in Q3 2023.
  • Worth Venture Partners opened 30 new positions and closed 35 in Q3 2023.
  • Worth Venture Partners's portfolio value fell 8.2% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.